Corrigendum to 'PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor' [Volume 14, Issue 9, September 2021, 101152]
- Resource Type
- article
- Source
- Translational Oncology, Vol 17, Iss , Pp 101344- (2022)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 1936-5233